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Abstract 
Dietary restriction promotes cell regeneration and stress resistance in multiple models 
of human diseases. One of the conditions that could potentially benefit from this 
strategy is Alzheimer’s disease, a chronic, progressive and prevalent 
neurodegenerative disease. Although there are no effective pharmacological 
treatments for this pathology, lifestyle interventions could play therapeutic roles. Our 
objectives were 1) to evaluate the effects of dietary restriction on cognition, 
hippocampal amyloid deposition, adult neurogenesis and glial reactivity and autophagy 
in a mouse model of familial Alzheimer’s disease, and 2) to analyze the role of glial 
cells mediating the effects of nutrient restriction in an in vitro model. Therefore, we 
established a periodic dietary restriction protocol in adult female PDAPP-J20 
transgenic mice for 6 weeks. We found that dietary restriction, not involving overall 
caloric restriction, attenuated cognitive deficits, amyloid pathology and microglial 
reactivity in transgenic mice when compared with ad libitum-fed transgenic animals. 
Also, transgenic mice showed an increase in the astroglial positive signal for LC3, an 
autophagy-associated protein. In parallel, hippocampal adult neurogenesis was 
decreased in transgenic mice whereas dietary-restricted transgenic mice showed a 
neurogenic status similar to controls. In vitro experiments showed that nutrient 
restriction decreased astroglial and, indirectly, microglial NFκB activation in response to 














autophagic flux and to decrease intracellular amyloid after exposure to amyloid β 
peptides. Our results suggest neuroprotective effects of nutrient restriction in 




Aβ Amyloid beta 
AD Alzheimer’s disease 
AL Ad libitum diet 
APP Amyloid precursor protein 
BAF Bafilomycin A1 
CM Conditioned medium 
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DCX Doublecortin 
DG dentate gyrus 
DR Dietary restriction 
GCL Granular cell layer 
GFAP Glial fibrillary acidic protein 
NR Nutrient restriction 
NTg Non-transgenic 




Alzheimer’s disease (AD) is a chronic, progressive pathology characterized by brain 
protein aggregation associated to neurodegenerative changes, ultimately leading to 
cognitive impairment and dementia. Its main histopathological hallmarks are cerebral 














the disease, astrocytes and microglia lose their homeostatic and neuroprotective 
functions and promote inflammation, even before amyloid β (Aβ) deposition (Beauquis 
et al., 2014; Olabarria et al., 2010; Pomilio et al., 2016). At later stages, extensive 
neurodegeneration leads to dementia.  
Although there are no effective treatments for AD, lifestyle changes were described in 
association with reductions in its incidence and progression. Among these, routinely 
carrying out physical, social and intellectual activities is one of the most promising 
strategies to delay disease progression (Ngandu et al., 2015). In recent years, attention 
has been put into dietary restriction (DR) as a potential neuroprotective strategy. 
Evidence suggests that DR of food intake could lead to the prevention of chronic 
diseases and to increase longevity in different animal models (Mattson, 2005; McCay 
et al., 1935), modulating energy metabolism, antioxidant defenses, inflammation and 
autophagy, among other pathways (Liu et al., 2017). Moreover, DR can prevent age-
related alterations in motor and cognitive function, dendritic plasticity and glial function 
in rats and mice (Ma et al., 2018; Mladenovic Djordjevic et al., 2010; Moroi-Fetters et 
al., 1989), potentially reducing the impact of age-associated diseases. Results from 
human studies and animal models suggest that DR could prevent AD-associated brain 
changes through multiple mechanisms including neuroprotection, glial modulation and 
amyloid clearance (Halagappa et al., 2007; Luchsinger et al., 2002; Patel et al., 2005). 
One of the processes that results up-regulated after DR is autophagy, a catabolic 
mechanism that degrades and recycles organelles and misfolded proteins like Aβ and 
could play a role in its clearance from tissues (Nilsson et al., 2013). Interestingly, AD-
associated phenomena like inflammation and glial activation can have an effect on 
autophagy functionality, further amplifying neurodegeneration (Alirezaei et al., 2011). 
Despite the plethora of health benefits that have been described in association to 
caloric restriction, one important concern is the effect of this strategy on body weight 
and energy metabolism. As in other age-associated diseases, weight loss could be a 














(Tamura et al., 2007). Most DR protocols involve caloric restriction and consequently 
lead to weight loss in variable percentages. Therefore, periodic schedules of DR that 
do not induce an overall decrease of caloric intake are potentially clinically-translatable 
alternatives (Brandhorst et al., 2015).  
In the present work our objective was to study the effects of a periodic DR protocol, 
which does not induce weight loss, on the modulation of experimental AD-associated 
cognitive and brain changes in a transgenic mouse model of the pathology. 
Complementarily, an in vitro approach was implemented to analyze glial responses to 
amyloid exposure and nutrient restriction. We studied astroglial autophagy and Aβ 
content in autophagosomes as evidences of a potential clearance pathway, and 
microglial activation as a pathogenic and modifiable event in experimental AD. 
 
2. Materials and Methods. 
2.1. Animals. 
Female adult PDAPP-J20 (PDGFB-APPSwInd) transgenic (Tg) mice and their 
nontransgenic (NTg) siblings were obtained from our colony at the animal facility of 
the Institute of Biology and Experimental Medicine (IBYME-CONICET; NIH Assurance 
Certificate # A5072-01). Breeders were provided by Dr. Verónica Galván from the 
University of Texas San Antonio Health Science Center. These mice carry the amyloid 
precursor protein (APP) human gene with Swedish and Indiana mutations for familial 
AD obtained through crossing hemizygous transgenic males with C57BL/6J (Jackson 
Lab.) female mice (Mucke et al., 2000). Transgenic mice were genotyped through PCR 
with specific human APP primers. Non-transgenic mice were used as controls. Animals 
were housed in groups of 3 to 5 individuals per cage with controlled humidity and 
temperature under a standard light/dark cycle with lights on at 7 a.m. All animal 
experiments followed the NIH Guide for the Care and Use of Laboratory Animals 
(https://www.ncbi.nlm.nih.gov/books/NBK54050) and were approved by the Ethical 














made to reduce the number of mice used in the study as well as to minimize animal 
suffering and discomfort. 
2.1.1. Experimental protocol. 
Female 6.5 month-old Tg and NTg mice were divided into ad libitum (AL) or dietary 
restriction (DR) groups. All animals were fed standard rodent chow (GEPSA Feeds, 
Pilar, Argentina) from weaning until the end of the experimental protocol at 8 months of 
age. Daily food intake was measured during the last 5 days before starting the 
restriction protocol in order to calculate the 60% intake amount that was later provided 
during the DR periods. The periodic DR protocol is depicted in figure 1 A. Individuals in 
the DR group underwent 3 cycles of DR-AL periods with each cycle lasting 2 weeks 
and consisting of 5 days of DR followed by 9 days of AL diet. The areas under the 
curve for food intake in each period were calculated using Prism 7.0 (GraphPad 
Software Inc.). Ad libitum-fed mice had free access to food pellets during all the 
experimental protocol. Weight and fasting glycemia were measured before the 
beginning of the DR protocol and before euthanasia using a glycometer (One Touch 
Ultra, Johnson & Johnson, Argentina). Euthanasia was performed at the end of the 
experimental protocol by injection of ketamine (80 mg/kg BW, i.p.; Holliday-Scott, 
Argentina) and xylazine (10 mg/kg BW, i.p.; Bayer, Argentina) and transcardial 
perfusion with 0.9% NaCl followed by 4% paraformaldehyde. 
2.1.2. Behavioral evaluation. 
Behavioral testing was done at 5 and 8 months of age in order to evaluate the cognitive 
status before and after the dietary intervention (n=8 per group). At 5 months of age we 
conducted a novel object-location recognition test (NOL) in groups of Tg and NTg mice 
as previously published (Beauquis et al., 2014). Mice were tested in a black plastic box 
(30 x 30 x 30 cm3) to which they were adequately habituated for 6 days prior to the 
trial. The test consisted of two 10-min trials (sample trial or T1 and test trial or T2) 
separated by a 1-h inter-trial interval (short-term memory). In T1, mice were exposed to 














whereas during T2, one of the objects was moved to a novel location in the opposite 
corner respective to the non-displaced object. Exploration of the objects was 
considered positive when the animals’ snout was facing the objects at less than 1 cm 
away. Performance was assessed as the percentage of time exploring the object in the 
novel location to total exploration time in T2. Exploration of the objects in T1 was 
quantified in order to determine the correct habituation to the objects, establishing 20 s 
as the inclusion time criteria. Also non-preference for any of the objects/box sectors in 
T1 was confirmed. In the last week of the protocol at 8 months of age and when all the 
groups were fed ad libitum, behavioral testing was done using the Y-maze task 
(Vinuesa et al., 2016). We did not run the NOL test at this time point in order to avoid a 
possible interference of the past experience of these mice in the test arena. The Y-
maze apparatus consisted of a black maze with three 30 cm long-arms in an equal 
angled disposition. Mice were adequately habituated to the room where the tests are 
carried out. The test consisted of two 10-min trials (sample trial or T1 and test trial or 
T2), separated by a 4-h inter-trial interval (intermediate-term memory). During T1, mice 
were allowed to explore two of the three arms, while during T2, exploration of the third 
novel arm was permitted. Having verified that exploration in T1 was not different from 
the 50% in either arm, behavior in T2 was evaluated as the percentage of time 
exploring the novel arm to total exploration time in T2. Locomotor activity, measured as 
total distance, was assessed in both tests with Any-maze video tracking system 
(Stoelting Co., USA) and no differences were found between groups. 
2.1.3. Tissue processing, Congo red staining and immunohistochemistry. 
After euthanasia, brains were dissected out of the skull and the hemispheres were 
separated. Hippocampi were dissected from the left hemispheres and frozen in dry ice 
for protein analysis. The right hemispheres were fixed overnight with paraformaldehyde 
4%, coronally cut at 60 μm using a vibrating microtome (PELCO easiSlicer, Ted Pella, 
USA) and sections corresponding to the hippocampus were stored in cryoprotectant 














analyses. Congo red staining was done to detect brain amyloid deposition as 
previously published (Pomilio et al., 2016). Immunohistochemistry and 
immunofluorescence were performed on 6 serial brain sections per mouse using a 
free-floating technique for doublecortin (goat polyclonal, 1:500, sc-8066, SCBT, USA), 
GFAP (rabbit polyclonal, 1:300, G-9269 or mouse monoclonal, 1:300, G-3893, Sigma, 
USA), Iba1 (rabbit polyclonal, 1:1500, Wako Chemicals, Japan), LC3 (rabbit polyclonal, 
1:500; NB100-2331, Novus Biologicals, USA) and Aβ (4G8 mouse monoclonal, 1:1000, 
MAB1561, Chemicon, USA). Briefly, sections were thoroughly rinsed in PBS to 
eliminate cryoprotectant solution before blocking of unspecific antigenic sites with 
rabbit (for DCX) or goat (for GFAP and Iba1) normal serum. For DCX staining, 
inhibition of endogenous peroxidase was done by incubating sections in 
Metanol:PBS:H2O2 (1:1:0.1). Sections were incubated overnight with primary 
antibodies and subsequently with corresponding secondary biotinylated (anti-goat, anti-
rabbit and anti-mouse; 1:1000, Vector Labs, USA) or fluorescent (Alexa 488/555 anti-
rabbit and anti-mouse, 1:1000, Invitrogen, USA) antibodies. 
2.1.4. Histological analyses. 
2.1.4.1. Quantification of hippocampal amyloid load.  
Microphotographs of the hippocampus were obtained from Congo red stained serial 
brain sections using a Nikon E-200 microscope. For amyloid load estimation, the total 
area of the dentate gyrus and its Congo red-positive subarea were measured on 
spatially calibrated images with a user-defined threshold to identify stained areas using 
ImageJ software (Abramoff et al., 2004). The results were expressed as the 
percentage of the dentate gyrus area covered by Congo red+ amyloid deposits (n=5 
per group). The total number of Congo red+ deposits was estimated using Cavalieri’s 
principles on serial hippocampus sections and also the size-distribution of plaques was 
calculated. 














Doublecortin-positive cells were counted in the subgranular zone (SGZ) and granular 
cell layer (GCL) of the dentate gyrus (DG) under a 40X objective using a Nikon E-200 
microscope. Every eighth 60 µm coronal brain section throughout the entire 
rostrocaudal extension of the DG were analyzed in each mouse (n=5 per group). The 
total number of cells was estimated using Cavalieri’s principle. Both upper and lower 
blades of the GCL and SGZ were considered for cell counting. The results are shown 
for dorsal and ventral dentate gyrus separately and expressed as the total number of 
DCX+ cells in each compartment.  
2.1.4.3. GFAP immunoreactive area and Sholl analysis. 
Immunoreactive area of GFAP+ astrocytes was calculated using a user-defined 
threshold on 8-bit bright-field images of hippocampal sections (n=5 per group). Results 
were expressed as the percentage of the hilus region covered by GFAP+ areas. Sholl 
analysis of GFAP+ cells was done following previously published protocols (Beauquis 
et al., 2010). Briefly, multiple confocal planes were obtained from GFAP-fluorescently 
stained hippocampal sections and averaged to generate Z-stacks. Averaged images 
were traced to obtain binary versions devoid of background staining, scaled and 
analyzed with ImageJ running Sholl Analysis Plugin (written by Tom Maddock; Ferreira 
et al., 2014). A minimum of 25 GFAP+ cells per animal were evaluated (n=5 per 
group). Results were expressed as the mean number of intersections per each radius-
defined circle  
2.1.4.4. LC3 content in hippocampal astrocytes. 
Quantification of hippocampal LC3 and GFAP astroglial levels was done on confocal 
images of GFAP-LC3 immunofluorescence (n=5 per group). Manders’ coefficient was 
calculated using the JACoP plug-in (Bolte and Cordelieres, 2006) for ImageJ software 
on thresholded images. Results were expressed as the M2 coefficient representing the 
proportion of the GFAP+ area that was also positive for LC3. 














Microglial soma size was measured on calibrated microphotographs from randomly 
chosen individual cells in the hilus of the DG. Somata were delineated and their surface 
quantified using ImageJ software. Activation score was calculated using a previously 
published protocol (Pomilio et al., 2016). Briefly, three microglial morphological 
activation phenotypes were defined: ramified (non-activated), reactive, and ameboid, 
representing progressive activation stages (Fig. 4 D). Using a randomly placed 6 × 105 
µm3 counting probe, the proportion of each phenotype was analyzed. The activation 
score was calculated as the sum of the multiplication of each morphology proportion by 
a numerical factor: 0 for ramified, 1 for reactive and 2 for ameboid. At least 50 cells 
were measured in each animal (n=5 per group). 
2.1.5 Immunoblotting. 
Interleukin 1 β (IL1β) contents were determined in hippocampi by immunoblotting. 
Samples were homogenized by sonication in supplemented RIPA buffer and protein 
levels were quantified using the Bradford method (Bradford, 1976). Then, after lysis 
with loading buffer, homogenates were loaded onto 12% acrylamide gels, separated by 
SDS-PAGE and transferred to nitrocellulose membranes. Membranes were blocked 
with 5% non-fat milk in TBS 0.5% Tween-20 and then incubated overnight at 4ºC with 
antibodies raised against IL1β (mouse monoclonal, 1:500 sc-32294, SCBT) or β-Actin 
(mouse monoclonal, 1:500, sc-47778, SCBT). After rinsing, membranes were 
incubated with an HRP-conjugated secondary antibody (goat anti mouse, 1:2000, sc-
2064, SCBT) for 1 hour. Immunoreactivity was visualized with detection reagents 
(luminol and p-coumaric acid; Sigma, USA) using an Amersham Imager 600 RGB (GE 
Healthcare, USA). Bands were quantified using the ImageJ plugin for gel analysis and 
ratios of IL1β/β-actin (n=5 hippocampi per group) levels were calculated. 
2.2. Cell culture. 
Astroglial and microglial in vitro experiments were done using C6 and BV2 cell lines, 
respectively. Rat astrocytoma C6 cell line (ATCC CCL-107) (Benda et al., 1968) was 














Mouse BV2 microglial cell line was provided by Dr. Guillermo Giambartolomei (Hospital 
de Clínicas, Buenos Aires, Argentina). Both cell lines were cultured in RPMI 1640 
medium (Gibco, USA) supplemented with 10% Fetal Bovine Serum (FBS; 
Internegocios SA, Argentina), 2.0 mM glutamine, 100 units/mL penicillin and 100 
mg/mL streptomycin. Cells were cultured at 37ºC in a humidified atmosphere of 5% 
CO2/95% air. 
2.2.1. Nutrient restriction, amyloid β exposure and bafilomycin treatment. 
Nutrient restriction (NR) was performed by incubation of astrocytes or microglia with 
RPMI + 2% FBS (control medium: RPMI + 10% FBS) for 6 hours. Afterwards, cells 
were exposed to Aβ 1-42 peptides (A9810, Sigma, USA), pre-fibrilized by incubation in 
water at 37ºC for 72 hours, using two different protocols. For the collection of astrocyte-
derived conditioned medium (CM), amyloid peptides were adsorbed to nitrocellulose at 
the bottom of the plate to ensure an amyloid-free medium to subsequently stimulate 
microglia (Combs et al., 2001). Briefly, 1 cm2 of nitrocellulose (GE, USA) was dissolved 
in methanol, pipetted to the bottom of culture wells and allowed to dry before adding Aβ 
peptides at 3 µM (Lagenaur and Lemmon, 1987). After rinsing, cells were seeded and 
exposed to the peptide for 24 h. Conditioned medium was collected, centrifuged and 
used at a 1:1 dilution in complete RPMI medium to stimulate BV2 microglia for 2 (NFκB 
immunocytochemistry) or 24 hours (MTT assay). For NFκB immunocytochemistry on 
astrocytes, Aβ peptides were dissolved in the culture medium at 0.5 µM for a 2 hour-
exposure after NR (or non-restricted conditions). Fixation was achieved by incubation 
with ice-cold methanol for 5 minutes. For studying astroglial autophagy, NR was done 
for 6 hours on C6 cells, as detailed previously, prior to Aβ 1-42 or control medium 
incubation for 2, 6 or 24 hours to understand the progression of the process. A group of 
NR Aβ cells in each protocol were treated with bafilomycin A1 (BAF; Fermentek, 
Israel), a negative regulator of the autophagic flux that inhibits lysosomal degradation, 
to determine if the effects of NR required a functional autophagy. Treatment with BAF 














2.2.2. MTT viability assay. 
3-(4,5-Dimethyl-thiazol-2-yl)22,5-diphenyl-tetrazolium bromide (MTT) reduction assay 
was carried out according to the previously described protocol (Pomilio et al., 2016). 
After exposure to astrocyte CM, microglial cells were grown on 96-well plates, rinsed 
with PBS and incubated with MTT (Sigma, USA) 0.125 mg/mL in RPMI media for 90 
minutes at 37ºC. Then, the product formazan was solubilized in DMSO and 
absorbance was measured at 570 nm with background subtraction at 655 nm in a BIO-
RAD Model 680 Benchmark microplate reader (Bio-Rad Laboratories, USA). The MTT 
reduction activity was expressed as a relative ratio to RPMI-incubated cell absorbance. 
2.2.3. Immunocytochemistry. 
After fixation with methanol, NFκB immunocytochemistry was performed on C6 and 
BV2 cells to determine nuclear translocation as a proxy for cell activation. 
Immunofluorescence against Aβ/LC3 was done on C6 cells to determine if intracellular 
Aβ was associated to autophagic vesicles as previously reported (Pomilio et al., 2016). 
Cells attached to coverslips were permeabilized with 0.5% triton X-100 in PBS and 
unspecific binding sites were blocked with 1% BSA in PBS. Cells were incubated with 
primary antibodies for LC3 (rabbit polyclonal, 1:1000; NB100-2331, Novus Biologicals, 
USA), Aβ (4G8 mouse monoclonal, 1:1000, MAB1561, Chemicon, USA) or NFκB 
(rabbit polyclonal, 1:1000, sc-372, SCBT, USA) and then with Alexa Fluor (488/596; 
Invitrogen, Thermo Fisher, USA) labeled secondary antibodies. Nuclei were visualized 
with DAPI (D9542, Sigma, USA) and coverslips were mounted on glass slides with 
PVA-DABCO (Sigma, USA). 
2.2.4. Quantification of immunoflorescence images. 
Quantification of LC3-Aβ immunofluorescence was done using ImageJ software. 
Individual cell areas from spatially calibrated images were outlined and measured 
before applying a threshold to measure immunopositive areas for each fluorophore. 
The analysis of co-localization between both markers was done using JACoP plug-in 














Mander’s coefficient). Nuclear translocation of NFκB was evaluated by measuring the 
optical density on 8-bit grayscale images (OD; 0=black, no staining; 255 white, max. 
staining) of the specific NFκB staining on the nucleus and on the cytoplasm of each 
cell. Then, results were expressed as the nucleus OD/cytoplasm OD ratio. Higher 
values indicated higher nuclear translocation. 
2.3. Statistical analysis 
The acquisition and analysis of experimental data were performed under blind 
conditions regarding group information. Statistical analyses involved unpaired one-
tailed Student’s t test, two-way ANOVA with Tukey’s or Dunnett’s post hoc tests or  
repeated measures (RM)- ANOVA, as detailed for each experiment in the Results 
section, and were performed with Prism 7.0 (GraphPad Software Inc.). Data are 
expressed as mean ± SEM. The sample size was calculated using StatMate 2.0 
(GraphPad Software Inc.) considering the results from our previous studies to obtain a 
5% statistical significance with 80% statistical power to detect differences of at least 
10% between groups. Group size is detailed in figure legends for each experiment..  
3. Results. 
3.1. Glycemia and body weight are not significantly affected by dietary 
restriction. 
Glycemia at 6.5 months of age, before commencing the DR, was lower in Tg compared 
with NTg mice (Student’s t test, p<0.01; Fig. 1 B). Comparison of glucose levels at the 
end of the last AL period showed a genotype effect (Two-way ANOVA, p<0.01; Fig. 1 
C) without differences within genotypes (Tukey’s post hoc test). Food intake for the DR 
groups was measured during each AL period after DR to check for a compensation 
effect. A rebound effect was noticed predominantly on the first and second days of the 
AL period with a normalization of food intake from the third day onwards (Fig. 1 D). 
Mean Kcal consumed per mouse daily during DR-AL cycles was compared with pre-














cycle 6.87 vs. pre-DR 6.82 Kcal/day/mouse, p=0.75) indicating the absence of overall 
caloric restriction with this diet. Moreover, areas under curve for DR and AL periods 
were similar (DR -13.2±1.97 vs. AL 13.94±1.87, net area 0.74, CI 95%=06.057). Body 
weight was measured at the beginning and at the end of each DR/AL period. Although 
a slight ~10% decrease in body weight was evident at the end of each DR period and a 
compensatory increase after each AL period, mice did not show weight loss at the end 
of the experimental protocol (RM-ANOVA for weight evolution and Tukey’s post hoc 
test for the comparison of the percentage change in final/initial body weight, p=0.98 for 
NTg and p=0.89 for Tg under DR; Fig. 1 E). Mice under the ad libitum diet showed a 
10-15% increase in body weight at the end of the protocol when compared with their 
initial weight (Tukey’s post hoc test, p<0.0001 both for NTg and Tg under AL diet). 
 
Figure 1. A. Experimental design. AL: ad libitum; DR: dietary restriction; NOL: Novel 














***p<0.001 (Student’s t test). C. Fasting glycemia at 8 months of age. D. Mean daily 
food intake (Kcal) per mouse during DR and AL periods. The dotted line represents 
6.875 Kcal corresponding to mean daily food intake per mouse measured for one week 
before starting the DR protocol. E. Body weight percent change before DR (pre-DR), at 
the end of each DR period (DR1, DR2 and DR3) and at the end of each AL period 
(AL1, AL2 and AL3/final weight), n = 5-11 animals per group.   
3.2. Dietary restriction ameliorates memory deficits of transgenic mice. 
At 5 months of age, 6 weeks before the beginning of the dietary intervention, mice were 
tested with the novel object-placement recognition task to analyze hippocampus-
dependent spatial memory. Control mice showed a significant preference for the 
displaced object (p<0.001, one-sample Student’s t test vs. 50% theoretical mean; Fig. 
2 A-B) while transgenic mice performed at chance level (p>0.05), indicating an 
impairment of spatial memory. At 8 months of age, after finishing the diet protocol, 
spatial memory was evaluated using a Y-maze test analyzing the exploration time of 
the novel arm. Non-transgenic mice both under AL and DR regimens preferentially 
explored the novel arm of the maze (p<0.05 vs. 33% chance level; Fig. 2 C-D). 
Exploration time of the previously blocked arm by ad libitum-fed transgenic mice was at 
chance level (p>0.05, one-sample Student’s t test vs. 33% chance level) suggesting an 
inability to recognize it as a novel environment. However, dietary restricted transgenic 
mice were able to identify the novel arm, evidenced by an increased preference 















Figure 2. A. Graphical representation of the novel object-placement recognition test. 
During the acquisition phase (T1) mice were allowed to explore both objects for 10 
minutes and then returned to their home cages for 60 minutes. In the test phase (T2) 
one object was displaced and exploration time was measured for 10 minutes. B. 
Performance expressed as the percentage of the relocated object exploration time/total 
exploration time. ***p<0.001 vs. 50% theoretical mean as the chance level 
(onesample Student’s t test). C. Graphical representation of the Y-maze test. During 
the acquisition phase (T1) mice were allowed to explore two arms of the arena for 10 
minutes and then returned to their home cages for 240 minutes. In the test phase (T2), 
access to the previously blocked arm was allowed and exploration time was measured 
for 10 minutes. D. Performance expressed as the percentage of novel arm exploration 
time/total exploration time *p<0.05 vs. 33% theoretical mean as the chance level 
(onesample Student’s t test), n = 7-10 animals per group.  
 
3.3. Dietary restriction prevents the impairment of adult neurogenesis in APP 














In order to study the potential implication of adult hippocampal neurogenesis as a 
subjacent process for the cognitive changes described in the previous section, we 
performed an immunohistochemistry for doublecortin (DCX) on coronal brain sections 
(Fig. 3 A). The number of DCX+ cells was quantified in the dorsal and ventral dentate 
gyrus and the analysis showed that Tg AL mice had fewer number of cells compared 
with NTg AL animals in both compartments (p<0.01 for dorsal DG and p<0.05 for 
ventral DG, Tukey’s post hoc test, two-way ANOVA, Fig. 3 B-C). Dietary restriction in 
transgenic animals led to a DCX cell number similar to control levels and different from 
Tg AL (p<0.05 for dorsal DG and p<0.01 for ventral DG, Tukey’s post hoc test). A 
tendency towards a decrease in the number of DCX+ cells in the ventral DG of NTg DR 
mice was noted although this difference was not statistically significant (p=0.14 vs. NTg 















Figure 3. A. Representative microphotographs of DCX immunostained neurons in the 
dentate gyrus. Scale bars: 200 µm (upper panel) and 80 µm (lower panel). B and C. 
Number of DCX+ cells in the dorsal (B) and ventral (C) dentate gyrus. *p<0.05; 
**p<0.01 (Tukey’s post hoc test, two-way ANOVA). D. Hippocampus coronal sections 
showing Congo red staining for amyloid in transgenic mice under ad libitum (AL) or 














bar: 300 μm. E. Amyloid load in the dentate gyrus. F. Number of Congo red+ plaques 
in the dentate gyrus. **p<0.01 (Student’s t test). G. Size distribution of Congo red+ 
plaques. **p<0.01 at the 25-50 µm2 size range, Bonferroni’s post hoc test, RM two-way 
ANOVA), n = 5-7 animals per group. 
 
3.4. Dietary restriction is associated with a decreased amyloid load in the 
hippocampus. 
Congo red staining was performed to detect amyloid deposition in the hippocampus of 
Tg mice (Fig. 3 D). Non-transgenic controls did not show detectable staining. 
Transgenic mice that underwent dietary restriction showed significantly less number of 
amyloid deposits as well as a diminished amyloid load (% Congo red area/reference 
area) in the dentate gyrus of the hippocampus compared with the Tg AL group (p<0.01 
for both comparisons, Student’s t test, Fig. 3 E-F). The analysis of the size-distribution 
of plaques showed that the effect of DR was predominant on the 25-50 µm2 size range 
(p<0.01, Bonferroni’s post hoc test, RM two-way ANOVA, Fig. 3 G). 
3.5. Astroglial morphology in the hippocampus. 
The analysis of GFAP immunostained astrocytes was done by evaluating the 
immunoreactive area and the cell processes complexity (Sholl analysis) in the hilus of 
the hippocampus (Fig. 4 A). Regarding GFAP immunoreactive area, a genotype effect 
was found (Two way ANOVA, p<0.01, Fig. 4 B) with both Tg AL and Tg DR groups 
showing increased levels compared with NTg AL (p<0.05, Tukey’s post hoc test). No 
differences were found between groups in the processes complexity (RM ANOVA, Fig. 
4 C). 
3.6. Increased microglial soma area in transgenic mice is prevented by dietary 
restriction. 
We analyzed microglial soma area in the hilus of the dentate gyrus on Iba1 
immunostained brain sections (Fig. 4 D). The analysis of this parameter showed that 














Tg AL vs. NTg AL, Tukey’s post hoc test, two-way ANOVA; Fig. 4 E). Interestingly, 
microglial soma areas of transgenic mice under dietary restriction were not different 
from control microglia. We evaluated microglial activation by means of a morphological 
score (Fig. 4 F) and found a genotype effect (two-way ANOVA, p<0.01) with no 
differences between individual groups (Tukey’s post hoc test). 
 
Figure 4. A. Representative microphotographs of GFAP-stained hippocampal sections. 
Scale bar: 100 µm. B. GFAP+ immunoreactive area in the hilus of the hippocampus 
(p<0.01, genotype effect, two-way ANOVA),. C. Histogram for circle intersections on 
the Sholl analysis of GFAP+ astrocytes. D. Representative microphotograph of an Iba1 
immunostained hippocampal coronal section comprising the granular cell layer (GCL) 
and the hilus (upper panel) and microphotographs of microglia assigned to each 
activation state (lower panel). Scale bars: 100 μm (upper panel) and 10 μm (lower 














ANOVA). F. Microglia activation score (p<0.05, genotype effect, two-way ANOVA). n = 
4-6 animals per group for histological analyses. G. IL1β and actin immunoblotting on 
hippocampus homogenates. H. IL1β /actin relative levels (p<0.05, diet effect, two-way 
ANOVA), n = 5 hippocampi per group. 
3.7. Dietary restriction is associated with lower IL1β levels in the hippocampus. 
We analyzed hippocampal IL1β protein levels by immunoblotting and found that DR 
groups showed lower levels than AD groups for both genotypes (p<0.05, diet effect, 
two-way ANOVA), without genotype effect or interaction (Fig 4 G-H). 
3.8. Amyloid β and nutrient restriction modulate NFκB nuclear translocation on 
astrocytes in vitro. 
Astrocytes from the C6 cell line were incubated for 6 hours with RPMI supplemented 
with 10% fetal bovine serum (FBS; non-restricted control condition) or RPMI with 2% 
FBS (nutrient restricted; NR) and subsequently exposed to fibrillar Aβ 1-42 peptides or 
vehicle for 2 hours. To determine cell activation in response to Aβ peptides and NR we 
quantified the ratio of nuclear translocation of NFκB on confocal images (Fig. 5 A-B). 
The quantification showed an effect of amyloid treatment (p<0.05, two-way ANOVA) 
and increased translocation in astrocytes exposed to Aβ without NR compared with 
control (CTL) cells (p<0.05, Dunnett’s post hoc test; Fig. 5 A). Both NR CTL and NR Aβ 
groups were not different from control cells (Dunnett’s post hoc test). 
Lipopolysaccharide (LPS) treatment was used as a positive control for NFκB nuclear 
translocation and compared independently with the CTL group (Student’s t test; p<0.05 















Figure 5. A and C. NFκB nuclear translocation for Aβ-treated astrocytes (A) and 
microglia (C). *p<0.05 vs. CTL (Dunnett’s post hoc test, two-way ANOVA). 
Lipopolysaccharide (LPS) was used as a positive control for NFκB nuclear 
translocation and compared independently with the CTL group (Student’s t test; LPS 
vs. CTL, p<0.05 for C6 cells and p<0.0001 for BV2 cells, significance not shown in the 
graphs). B and D. Confocal images of NFκB-stained astrocytes (B) and microglia (D) 
under control conditions (upper panels) or activated after LPS treatment (lower panels). 
Arrowheads indicate cells with NFκB nuclear translocation. E. Microglial viability 
evaluated using the MTT assay after exposure to astrocyte-derived conditioned 
medium. *p<0.05 and ***p<0.001 vs. CTL (Tukey’s post hoc test, two-way ANOVA). F. 
NFκB nuclear translocation in conditioned medium-treated microglia. ***p<0.001 vs. 
CTL (Dunnett’s post hoc test, two-way ANOVA), results from at least 25 cells in 














3.9. Direct Aβ exposure or nutrient restriction do not induce changes in NFκB 
nuclear translocation in microglia in vitro. 
We exposed BV2 microglia to the same Aβ and NR protocol that was used in 
astrocytes to evaluate NFκB nuclear translocation (Fig. 5 C-D). Unlike astrocytes, 
microglia did not show changes in NFκB translocation upon Aβ or NR exposure 
(Dunnett’s post hoc test after Two-way ANOVA; Fig. 5 C). Exposure to LPS was used 
as a positive control for microglial activation and compared independently with the CTL 
group (Student’s t test; p<0.0001 LPS vs. CTL). 
3.10. Conditioned media from Aβ- and NR-exposed astrocytes increase 
microglial viability evidenced by the MTT assay. 
C6 astrocytes were incubated for 6 hours with RPMI + 10% FBS (non-restricted control 
condition) or RPMI + 2% FBS (NR) and then transferred to nitrocellulose-coated 
coverlips with pre-adsorbed Aβ (or vehicle) in RPMI +10% for 2 hours. Then, 
conditioned media (CM) were collected and applied using a 1:1 dilution in RPMI + 10% 
FBS on BV2 microglial cells. The analysis of MTT to formazan conversion showed 
increased cell viability of BV2 microglia in response to CM from Aβ-treated as well as 
from NR astrocytes when compared with CM from control cells (Tukey’s pot hoc test 
after two-way ANOVA; Fig. 5 E). Conditioned medium from untreated astrocytes was 
associated with absorbance values similar to those of non-conditioned RPMI-cultured 
microglia. 
3.11. Conditioned medium from Aβ-exposed astrocytes induces NFκB 
translocation on microglia but not if NR preceded Aβ-exposure.  
After confirming unspecific increased viability of microglia upon exposure to CM from 
Aβ- or NR astrocytes, we studied if CM from astrocytes were able to elicit differential 
activation of microglia, evaluated by NFκB nuclear translocation. We incubated 
microglia for 2 hours with CM from the different astrocyte culture conditions and found 
interaction between Aβ and nutrient factors (p<0.05, two-way ANOVA) and an increase 














Dunnet’s post hoc test; Fig. 5 F). In order to check for a possible CM-associated effect 
not mediated by astrocytes and derived from Aβ detaching from nitrocellulose we 
incubated microglia with medium from cell-free Aβ-coated wells and found that NFκB 
nuclear translocation level was not different from CTL CM-induced values (Student’s t 
test). 
3.12. Autophagy in hippocampal astrocytes and intracellular amyloid in vivo. 
As mentioned, one of the potentially involved pathways in amyloid processing is 
autophagy. A double immunofluorescence for LC3 to stain autophagic vesicles and 
GFAP to identify astrocytes was done on hippocampal sections (Fig. 6 A). A large 
proportion of the LC3+ areas co-localized with GFAP+ cells while a small percentage 
corresponded to hilar neurons or vascular regions. Quantification of the proportion of 
GFAP+ areas also positive for LC3 showed higher levels in transgenic mice, 
independently of the type of diet (two way ANOVA, p<0.01 for genotype effect; Fig. 6 
B). After confirming that autophagy was occurring in hippocampal astrocytes, we 
evaluated the relationship of LC3+ autophagic vesicles with amyloid β in the 
hippocampus of Tg mice. Using a double immunofluorescence for 4G8 to detect Aβ 
and LC3 for autophagic vesicles (Fig. 6 C) we identified Aβ co-localizing with LC3+ 
















Figure 6. A. Confocal images of GFAP (red) and LC3 (green) stained hippocampal 
sections for NTg and Tg experimental groups. Scale bar: 50 μm. B. M2 coefficient 
(proportion of GFAP+ areas that co-localize with LC3), n = 4 animals per group. C. 
Confocal image of 4G8 (red) and LC3 (green) immunofluorescence in the hilus of the 
hippocampus of a transgenic mouse showing an amyloid plaque (*) and an LC3+ cell 
that presents astrocyte morphology with 4G8+ amyloid inside (confirmed in the 
orthogonal XZ-YZ views). Scale bar: 10 µm. D. Confocal image of Aβ (red) and LC3 
(green) immunofluorescence on C6 astrocytes (DAPI in the blue channel). Scale bar: 
10 µm. E. Confocal images showing LC3 immunoreactivity in astrocytes from each 
experimental group with higher intensity in the Aβ and NR Aβ BAF groups. Scale bar: 
10 µm. F-N. Quantification of LC3+ and Aβ+ percent coverage of C6 cells and M2 
coefficient (percentage of Aβ+ areas that co-localize with LC3+ areas) for the three Aβ 














6-hour incubation and L-N corresponding to the 24-hour incubation. *** in E represents 
p<0.001 vs. every other group. In the other graphs: *p<0.05, **p<0.01 and ***p<0.001 
for the indicated comparisons (Tukey’s post hoc test, two-way ANOVA), results from at 
least 40 cells per group in triplicate samples from two independent experiments. 
Mean±SEM values: % LC3 2 hs CTL 1±0.15, NR CTL 0.71±0.16, Aβ 0.43±0.08, NR Aβ 
0.4±0.14, NR Aβ BAF 2.24±0.38; 6 hs CTL 1±0.22, NR CTL 3.24±0.56, Aβ 7.82±1.24, 
NR Aβ 1.6±0.29, NR Aβ BAF 4.31±0.77; 24 hs CTL 1±0.19, NR CTL 1.19±0.27, Aβ 
2.45±0.24, NR Aβ 1.19±0.19, NR Aβ BAF 3.72±0.25. % Aβ: 2 hs Aβ 1±0.177, NR Aβ 
1.1±0.2, NR Aβ BAF 1.86±0.32; 6hs Aβ 1±0.16, NR Aβ 0.43±0.05, NR Aβ BAF 
0.99±0.16, 24 hs Aβ 1±0.16, NR Aβ 0.49±0.08, NR Aβ BAF 1.08±0.07; M2 index: 2 hs 
Aβ 1±0.27, NR Aβ 1.54±0.54, NR Aβ BAF 4.2±1.13, 6 hs Aβ 1±0.21, NR Aβ 0.26±0,08, 
NR Aβ BAF 0.51±0.18, 24 hs Aβ 1±0.1, NR Aβ 0,68 ± 0,1, NR Aβ BAF 2.05±0.15. 
 
3.13 Nutrient restriction restores autophagic flux in Aβ-treated astrocytes in 
vitro. 
In order to study the autophagic flux and amyloid β content in astrocytes using an in 
vitro approach, we exposed astrocytes (C6 cell line) to NR (2% FBS) or control medium 
(10% FBS) for 6 hours, and then to fibrillar Aβ 1-42 peptides for 2, 6 or 24 hours to 
understand the progression of the process. In the last 2 hours of incubation, some cell 
groups were treated with bafilomycin A1 (BAF), a blocker of the autophagic flux, that, 
when applied to cells in which autophagy is active, causes an accumulation of LC3 due 
to reduced turnover. Afterward, immunofluorescence techniques to detect LC3 
(Autophagosomal marker) and amyloid beta (4G8 antibody) were performed (Fig. 6 D-
E). At the 2-hour Aβ incubation time, LC3 intracellular levels were not changed by Aβ 
exposure but were increased after the co-incubation with BAF (p<0.001 vs. every other 
group, Tukey’s post hoc test after two-way ANOVA for all the analyses in this 
subsection, Fig. 6 F), suggesting that autophagy was functional at this time-point. 














BAF-naïve cells (p<0.05, Fig. 6 G), suggesting that autophagy was active and could be 
involved in amyloid clearance. Also an increased proportion of intracellular Aβ was 
associated with LC3+ vesicles after BAF treatment, as evidenced by the evaluation of 
the M2 index for the co-localization of 4G8 and LC3 markers (p<0.01 vs. Aβ and 
p<0.05 vs. NR Aβ, Fig. 6 H).  
Astrocytes exposed to Aβ peptides for 6 hours showed an increase in LC3+ areas 
(p<0.001 vs. CTL), an effect that was not seen if the exposure to Aβ was preceded by 
NR (Fig. 6 I).  As co-incubation with BAF attenuated the effect of NR (p<0.05 vs. NR 
Aβ), it is reasonable to suggest that the increased levels of LC3 seen in the Aβ group 
could be due to blocked autophagy and that NR could be restoring the flux, hence 
lowering LC3 levels as shown. After a 6-hour Aβ incubation, cells that were previously 
nutrient-restricted had lower levels of Aβ compared with the Aβ-exposed non-restricted 
group (p<0.05, Fig. 6 J). This effect was lost after BAF treatment, suggesting that 
levels of intracellular Aβ deposits depend on a functional autophagic process. 
Regarding Aβ-LC3 co-localization, a lower percentage of Aβ was found associated to 
autophagosomes (M2 index; p<0.01, Fig. 6 K) which in a context of lower levels of 
intracellular Aβ could indicate degradation or externalization of the amyloid peptide. 
Exposure of astrocytes to Aβ for 24 hours showed that Aβ-treated cells had higher 
levels of LC3 compared with controls and that previous NR was able to decrease them 
to control levels (p<0.001 for both comparisons, Fig. 6 L), in a similar fashion to what 
was found in 6-hour Aβ-treated cells. Intracellular Aβ and co-localization of Aβ with LC3 
were both down-regulated by NR at this time-point (p<0.01 and p<0.05, Fig. 6 M and N 
respectively). Bafilomycin treatment for the last 2 hs of Aβ exposure increased LC3, Aβ 
and M2 levels (p<0.001, p<0.05 and p<0.001 respectively for the NR Aβ BAF vs. NR 
Aβ comparison) suggesting that autophagy is functional and involved in the regulation 
















Our results provide evidence that a periodic dietary restriction (DR) protocol on an 
animal model of AD can ameliorate multiple aspects of the pathology. Dietary 
restriction has been implicated in the reduction of brain amyloid deposits in multiple 
animal models of AD (Mouton et al., 2009; Patel et al., 2005; Schafer et al., 2015) but 
underlying mechanisms are not clear yet and many hypotheses have been formulated, 
mainly pointing either to a decrease in Aβ production or an increase in Aβ clearance. 
Among the first group, diminished expression of amyloidogenic secretases was 
described in response to 30% caloric restriction (Schafer et al., 2015) and modulation 
of APP processing towards the non-amyloidogenic pathway was associated to long-
term 30% carbohydrate caloric restriction (Wang et al., 2005), both in the Tg2576 
mouse AD model. Among the second group, some authors have suggested that the 
diet-induced modulation of glial activation could be playing a role in the phagocytosis of 
Aβ deposits (Patel et al., 2005). Also, as caloric restriction has been associated to the 
optimization of insulin signaling both peripherally and centrally, increased Aβ clearance 
could be mediated by decreased competition with insulin for the insulin-degrading 
enzyme (IDE) degrading activity (Farris et al., 2003).  
Autophagy, an important catabolic pathway necessary for the degradation of damaged 
organelles and aggregated proteins like Aβ could also be involved in the effects of DR. 
Caloric restriction is a powerful non-pharmachological inducer of the autophagic 
process (Dong et al., 2015; Yang et al., 2014).and although induction of autophagy as 
a neuroprotective strategy in AD has been studied mainly in neurons (Lin et al., 2013; 
Spilman et al., 2010), astroglial autophagy could participate in the uptake or 
degradation of amyloid peptides (Pomilio et al., 2016; Simonovitch et al., 2016). Also, 
microglia has been shown to be able to degrade extracellular amyloid fibrils in vitro 
through autophagy (Cho et al., 2014). Our present data shows that a fraction of Aβ co-
localizes with LC3+ autophagic vesicles in vivo and also in vitro and that a substantial 
proportion of hippocampal LC3+ areas co-localize with the astrocyte marker GFAP, 














analysis of LC3 in hippocampal sections showed increased levels of this protein in 
GFAP+ astrocytes of Tg mice. However, as autophagy is a dynamic process, this 
change could be due to an induction of autophagy or could be the result of impaired 
degradation of autophagosomes, as suggest our in vitro results. Also, the lack of effect 
of DR on astroglial LC3 levels does not necessarily imply an absence of effect on 
autophagy, as autophagosome formation and degradation could be balanced with no 
overall changes on LC3 immmunostaining. Further studies should be done in order to 
clarify these points. At short incubation times with Aβ, in vitro astroglial autophagy was 
not induced, though a certain amount of basal activity was present since bafilomycin 
treatment increased the LC3-immunoreactive area. Amyloid intracellular levels were 
higher after bafilomycin exposure indicating that a functional autophagy is necessary to 
regulate intracellular amyloid content. At longer incubation times (6 and 24 hours), Aβ 
exposure induced higher levels of LC3 astroglial content. Nutrient restriction diminished 
LC3+ areas to control levels and Aβ cell load to a ~50%. Interestingly, bafilomycin 
treatment reversed both effects suggesting that NR could be acting through a 
normalization of the autophagic flux. Unpublished results from our group suggest that 
Aβ could interrupt the glial autophagic flux through an inhibition of the fusion between 
the autophagosome and the lysosome, preventing cargo degradation. Also, lysosomal 
proteolysis malfunction could be a potential subjacent mechanism (Yang et al., 2011). 
The analysis of the LC3-Aβ co-localization in vitro showed that NR decreased the 
intracellular proportion of Aβ that was contained in autophagic vesicles in a context of 
lower Aβ levels, suggesting an increase in the degradation or externalization of amyloid 
peptides as proposed previously (Pomilio et al., 2016). Interestingly, there is evidence 
that glial autophagy could be induced by inflammatory stimuli and play a role in cell 
survival under acute inflammation but when blockage of the autophagic flux is also 
involved, high and non-physiological amounts of ROS are produced by glial cells 
(Motori et al., 2013), potentially amplifying tissue damage and inflammation 














accumulation, constituting a highly pro-inflammatory scenario that deserves further 
research to understand interplaying mechanisms and successful therapeutic 
interventions. 
Reversion of cognitive deficits in the PDAPP-J20 transgenic mice could be mediated by 
multiple mechanisms. One of the probably involved processes in the cognitive 
improvement associated to DR is the positive regulation of adult hippocampal 
neurogenesis. This process is regulated by hormones (Cameron and Gould, 1994), 
environment (Kempermann et al., 1998), running (van Praag et al., 1999), 
antidepressants (Malberg et al., 2000), among many other factors, and is likely 
involved in hippocampal-dependent learning (Marin-Burgin and Schinder, 2012). There 
is evidence that diet also plays a regulatory role on adult neurogenesis, either inhibiting 
or stimulating the process. Consumption of high-fat diets has been associated to 
decreased neurogenesis and synaptic plasticity (Boitard et al., 2012; Lindqvist et al., 
2006; Vinuesa et al., 2018; Vinuesa et al., 2016), possibly comprising inflammation and 
insulin resistance as subjacent elements. On the contrary, dietary restriction positively 
modulates hippocampal neurogenesis in animal models (Hornsby et al., 2016; Lee et 
al., 2002) with a potential impact on learning and memory. Among the identified 
pathways by which DR influences neurogenesis are protection against oxidative stress 
(Bruce-Keller et al., 1999), neurogenesis-related gene regulation (Wu et al., 2008) and 
upregulation of neurotrophic factors (Lee et al., 2000; Lee et al., 2002). Other probably 
underlying pathway was described by Ma et al. as they showed that caloric restriction 
can improve cognitive performance in control mice through activation of the PI3K/Akt 
pathways (Ma et al., 2014). Interestingly, one of the signals that can promote cognition 
in an AD model is hunger, independently of caloric intake (Dhurandhar et al., 2013), 
pointing to a neuroendocrine regulation of DR effects. 
Inflammation and glial activation are present since early stages in models of AD 
(Beauquis et al., 2014; Li et al., 2011; Pomilio et al., 2016) and mediators such as nitric 














progression. Dietary restriction can have a role in slowing brain aging associated to an 
attenuation of glial pro-inflammatory activation (Morgan et al., 2007; Sridharan et al., 
2013). Caloric restriction is able to decrease astrocyte activation and excitotoxic 
damage in different murine models of AD (Patel et al., 2005; Zhu et al., 1999). Radler 
et al. demonstrated that a 50% caloric restriction protocol attenuates LPS-induced 
microglial activation in discrete regions of mice brains, also suppressing LPS-
associated fever (Radler et al., 2014) and pointing towards a general regulation of anti- 
and pro-inflammatory signals. In the present study we have found a negative regulation 
of IL1β in the hippocampus of both NTg and Tg mice in response to dietary restriction, 
suggesting an anti-inflammatory effect. However hippocampal IL1β levels were similar 
for NTg and Tg animals, indicating that the inflammatory scenario in the PDAPP-J20 
Tg mouse at this age is not evidenced by changes in this marker, an observation that is 
consistent with reports in other models of AD in which inflammatory cytokines are 
found elevated at later ages (reviewed in Morgan et al., 2005). As our results show, 
astrocytes are capable of responding in vitro both to amyloid peptides and to nutrient 
restriction and also of transmitting pro- or anti-activation signals to microglia. Activation 
of microglia after NFκB translocation in astrocytes during neurodegeneration is 
dependent on several proinflammatory mediators like cytokines IL1β, IL6 and TNFα, 
ROS (Shih et al., 2015), chemokines (Brambilla et al., 2009) and members of the Wnt 
family (Ouali Alami et al., 2018), among others. Interestingly, while microglial cells were 
activated in an indirect fashion as a response to conditioned media from astrocytes, 
they did not show activation when directly exposed to these stimuli. This differential 
response could be due to a number of factors. Sondag et al. showed that primary 
microglia activation depends on the conformational state of amyloid peptides, finding 
different degree and quality of activation if using oligomers or fibrils (Sondag et al., 
2009). Moreover, though they show similar functional responses, it is possible that BV-
2 cells do not respond to Aβ in the same way as primary microglia (Jana et al., 2008). 














peptides than microglia and thus able to trigger a functional response to subtle 
microenvironmental changes. In a mouse model of experimental autoimmune 
encephalitis, Brambilla et al. have shown that the inactivation of astroglial NFκB 
reduced CNS inflammation and improved functional recovery, highlighting the 
regulatory role that astroglia plays in the inflammatory response (Brambilla et al., 
2009). Our in vivo study showed that dietary restriction prevented the increase in 
microglia soma size but did not affect astrocytic GFAP immunoreactive area. As these 
are morphological parameters of glial reactivity that do not provide specific information 
regarding the functional state of glial cells, a thorough characterization of astroglial and 
microglial activation using markers for different activation phenotypes is needed to 
draw solid conclusions.  
Activation of glial cells not only correlates with an increase of pro-inflammatory signals 
but also dampens basic supportive functions affecting the metabolic and energy 
homeostasis of the nervous system. In this sense, some authors consider AD as a 
brain metabolic pathology because of the multiple common pathways affected both in 
AD and metabolic diseases like type 2 diabetes mellitus, obesity, and metabolic 
syndrome (de la Monte and Tong, 2014) and also because of the data showing brain 
insulin resistance (Biessels and Reagan, 2015), mitochondrial dysfunction (Demetrius 
et al., 2014) and disturbed bioenergetics (Sonntag et al., 2017) in patients and 
experimental models. As astrocytes play a crucial role in brain energy metabolism and 
neuroprotection, it is plausible to think that loss of these homeostatic functions, as a 
consequence of pro-inflammatory activation, could be an early and central event in the 
course of AD, preceding symptomatic phases of the disease (Rodriguez et al., 2009). 
Lactate derived from glycogen storages in brain astrocytes is considered an 
emergency fuel during endurance conditions (Matsui et al., 2017) and its availability is 
dependent on glial homeostatic capability. Peripherally, we found lower glycemic 
values in Tg mice compared with controls before the beginning of the DR protocol. 














possible that Tg mice have systemic metabolic imbalances, as described in other AD 
mouse models (Pedros et al., 2014; Vandal et al., 2015). Several studies point to a 
peripheral pathogenic role for amyloid peptides that could be mediated through 
pancreatic amyloid co-deposition (reviewed by Wijesekara et al., 2018). Also, 
inflammatory mediators can have a role on glucose regulation, both centrally and 
peripherally. In this sense, intracerebroventricular or intraperitoneal injection of IL-1β to 
mice induces hypoglycemia that is dependent on the action on the central IL-1β 
receptor (Del Rey et al., 2016). Hence, it is reasonable to propose that diseases 
associated with CNS inflammation and glial activation can be accompanied by 
peripheral metabolic disturbances.  
Although many epidemiological studies have reported a higher incidence and 
prevalence of Alzheimer’s disease in women, most pre-clinical research done in mouse 
models studied male subjects or male and female mice indiscriminately. Taking into 
account this bias, the present study was performed on female mice to evaluate, as a 
secondary objective, whether female PDAPP-J20 transgenic animals showed similar 
pathological progression as male mice. Our results showed that plaque load, 
neurogenic status and morphological parameters of glial activation paralleled those 
obtained in previous studies done in male animals (Beauquis et al., 2013; Pomilio et 
al., 2016). However, subsequent experimental designs including both genders would 
be desirable to allow the comparison of differential responses. 
 
5. Conclusion. 
Our results provide evidence of the attenuating effect of dietary restriction on multiple 
aspects of the pathology in PDAPP-J20 mice, model of Alzheimer’s disease. 
Complementarily, in vitro experiments showed that the autophagic process and cell 
activation are modulated by nutrient restriction in astrocytes exposed to amyloid 
peptides, suggesting a potential mechanism of action for this strategy. We consider 














restriction protocol is an important aspect to be taken into account when dealing with 
aging-associated conditions (Lee and Longo, 2016). Available data from the basic 
sciences suggest that dietary restriction could be useful not only for preventing or 
reducing the risk of AD but also for the reversion of pre-existing brain changes and 
cognitive deficits. Moreover, there is a great interest in developing dietary restriction-
mimetics that eliminate the need for diet changes (Van Cauwenberghe et al., 2016) 
though we consider that the multiple benefits associated to these dietary habits should 
not be understated (Mattson and Wan, 2005). Given the lack of effective 
pharmacological treatments for AD, lifestyle interventions, as multi-target strategies, 
are potentially valuable alternatives for the prevention and eventual management of the 
pathology. In this sense, dietary restriction would not only serve as a potential 
therapeutic strategy per se, but also contribute to the in-depth understanding of the 
pathways involved in the progression of both physiological and pathological aging. 
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 Dietary restriction (DR) could be a therapeutic strategy in age-associated 
diseases 
 DR attenuates amyloid load and memory deficits in mice modeling Alzheimer’s 
disease 
 Nutrient restriction (NR) decrease glial reactivity to amyloid peptides in vitro 
 NR-induced astroglial autophagy in vitro could play a role in amyloid processing 
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